Cargando…

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer

Lymphovascular invasion (LVI) and Black race are associated with poorer prognosis in early breast cancer (EBC). We evaluated the association between LVI and race, and whether LVI adds prognostic benefit to the 21-gene recurrence score (RS) in EBC. Women with ER+ HER2− EBC measuring up to 5 cm, with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makower, Della, Lin, Juan, Xue, Xiaonan, Sparano, Joseph A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921089/ https://www.ncbi.nlm.nih.gov/pubmed/33649322 http://dx.doi.org/10.1038/s41523-021-00231-x

Ejemplares similares

The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis
por: Makower, Della, et al.
Publicado: (2022)

Predictors of lymphovascular invasion in estrogen receptor positive/Her-2 negative breast cancer patients treated with neoadjuvant chemotherapy
por: ÇAVDAR, Eyyüp, et al.
Publicado: (2022)

Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion
por: Mahdi, Haider, et al.
Publicado: (2015)

Progress in adjuvant chemotherapy for breast cancer: an overview
por: Anampa, Jesus, et al.
Publicado: (2015)

The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes
por: Barbi, Mali, et al.
Publicado: (2021)

Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer
por: Li, Jun, et al.
Publicado: (2019)

The Impact of Lymphovascular Space Invasion on Recurrence and Survival in Iranian Patients With Early Stage Endometrial Cancer
por: Akhavan, Setareh, et al.
Publicado: (2016)

Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer
por: Yu, Jing, et al.
Publicado: (2021)

Lymphovascular invasion in hormone-positive, human epidermal growth factor-negative, low-burden axillary disease in early breast cancer patients tested for oncotype DX recurrence score
por: Al-Zawi, Abdalla Saad Abdalla, et al.
Publicado: (2022)

A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
por: Alvarado, Michael D., et al.
Publicado: (2015)

Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients
por: Wu, Jiayi, et al.
Publicado: (2017)

Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
por: Ma, Sung Jun, et al.
Publicado: (2023)

Updates on Lymphovascular Invasion in Breast Cancer
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer
por: Ni-jia-ti, Ma-yi-di-li, et al.
Publicado: (2020)

A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
por: Sparano, Joseph A., et al.
Publicado: (2017)

Risk Factors of Submucosal or Lymphovascular Invasion in Early Gastric Cancer <2 cm
por: Choi, Yu Yi, et al.
Publicado: (2016)

Association of Neighborhood-Level Household Income With 21-Gene Recurrence Score and Survival Among Patients With Estrogen Receptor–Positive Breast Cancer
por: Ma, Sung Jun, et al.
Publicado: (2023)

Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix
por: Murakami, Isao, et al.
Publicado: (2012)

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
por: Stemmer, Salomon M., et al.
Publicado: (2013)

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
por: Sparano, Joseph A., et al.
Publicado: (2021)

The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes
por: Wang, Jun, et al.
Publicado: (2018)

Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer
por: Ji, Jung Hwan, et al.
Publicado: (2022)

Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast Cancer
por: Lee, Janghee, et al.
Publicado: (2022)

Significance of lymphovascular space invasion in epithelial ovarian cancer
por: Matsuo, Koji, et al.
Publicado: (2012)

Lymphovascular Space Invasion in Robotic Surgery for Endometrial Cancer
por: Hopkins, Mark R., et al.
Publicado: (2014)

ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Prediction of lymphovascular space invasion in patients with endometrial cancer
por: Kim, Sang Il, et al.
Publicado: (2021)

Primary testicular carcinoid tumor with marked lymphovascular invasion
por: Lee, Hyun Jung, et al.
Publicado: (2021)

Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
por: Fried, Georgeta, et al.
Publicado: (2014)

Differences in Prevalence of Lymphovascular Invasion among Early Gastric Cancers between Korea and Japan
por: Lee, Sun-Young, et al.
Publicado: (2017)

The Role of Lymphovascular Invasion as a Prognostic Factor in Patients with Lymph Node-Positive Operable Invasive Breast Cancer
por: Song, Young Ju, et al.
Publicado: (2011)

A key genomic subtype associated with lymphovascular invasion in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Radiomics feature as a preoperative predictive of lymphovascular invasion in early-stage endometrial cancer: A multicenter study
por: Liu, Xue-Fei, et al.
Publicado: (2022)

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
por: Soliman, Hatem, et al.
Publicado: (2020)

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer
por: Yarandi, Fariba, et al.
Publicado: (2023)

The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
por: Chang, Yin Lun, et al.
Publicado: (2023)

Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer
por: Chen, Ming, et al.
Publicado: (2015)

Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion
por: Hoellen, Friederike, et al.
Publicado: (2016)

Lymphovascular invasion in testicular germ cell tumors: clinicopathological correlates
por: Yossepowitch, Ofer, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_60critnsorvrut67snt5mpvr9a